Inside Precision Medicine January 26, 2024
Malorye Branca

A new statistical tool developed at University of Chicago makes it quicker and easier to find genetic variants underlying disease. The tool, described in a paper today in Nature Genetics, combines data from genome wide association studies (GWAS) and predictions of genetic expression to better identify disease-causal variants. Causal-transcriptome-wide association studies (cTWAS) uses a Bayesian multiple regression model and can account for multiple genes and variants at once.

GWAS is often used to associate genes with human traits, including common diseases. But most human diseases are not caused by a single genetic variation, but rather are the result of a complex interaction of multiple genes, environmental factors, and other variables. GWAS, however, only identifies association, not causality. In a typical...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Biotechnology, Pharma / Biotech, Technology
Banner Health, Cleveland Clinic invest millions in analytics startup: 7 notes
Morgan Health Commits $25M to Merative to Enhance Employer Data Capabilities
Senior care centers should use data analytics to prioritize patient-centered care | Viewpoint
How Predictive Analytics Reduces Hospital Readmissions
Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Share This Article